Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes.

Yuusuke WatanabeYoshifumi SaishoJun InaishiKinsei KouAkira YamauchiYasuhiko KanazawaYoshiaki OkuboMikiya TokuiTakatoshi ImaiRie MurakamiTami TsuchiyaHironobu SasakiTatsuhiro MasaokaJunichiro IrieShu MeguroHiroshi Itohnull null

Published in: Journal of diabetes investigation (2019)

Switching from exenatide b.i.d. to exenatide q.w. resulted in a reduction in glycated hemoglobin, fasting plasma glucose and the incidence of hypoglycemia, and improvement in β-cell function and treatment satisfaction in patients with type 2 diabetes. These findings will be useful for selecting optimal treatment in individuals with type 2 diabetes.

Keyphrases

type diabetes
blood glucose
physical activity
risk factors
insulin resistance
metabolic syndrome
blood pressure
combination therapy
adipose tissue
weight loss